PHAXIAM Therapeutics S.A. (LON: 0QSS)
London
· Delayed Price · Currency is GBP · Price in EUR
1.820
+0.070 (4.00%)
Jan 21, 2025, 8:50 AM BST
PHAXIAM Therapeutics Employees
PHAXIAM Therapeutics had 68 employees as of December 30, 2023. The number of employees increased by 19 or 38.78% compared to the previous year.
Employees
68
Change (1Y)
19
Growth (1Y)
38.78%
Revenue / Employee
26.69K GBP
Profits / Employee
-273.32K GBP
Market Cap
15.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
PHAXIAM Therapeutics News
- 2 months ago - PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area - GlobeNewsWire
- 2 months ago - PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day" - GlobeNewsWire
- 2 months ago - PHAXIAM Reports Third-Quarter 2024 Financial Information - GlobeNewsWire
- 2 months ago - PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S. - GlobeNewsWire
- 4 months ago - PHAXIAM Provides Business and Financial Update For the First Half of 2024 - GlobeNewsWire
- 7 months ago - Results of the Combined General Meeting of 28 June 2024 - GlobeNewsWire
- 8 months ago - PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024 - GlobeNewsWire
- 9 months ago - PHAXIAM provides Business and Financial Update for the First Quarter of 2024 - GlobeNewsWire